MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KASLOW, H. R.
Right arrow Articles by BOURNE, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KASLOW, H. R.
Right arrow Articles by BOURNE, H. R.

Molecular Pharmacology, Vol 19, 406-410, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

An Mr = 52,000 Peptide Can Mediate Effects of Cholera Toxin on Adenylate Cyclase in Intact Cells

HARVEY R. KASLOW 1, DAVID COX 1, VINCENT E. GROPPI 1, and HENRY R. BOURNE 1

1 Division of Clinical Pharmacology, Departments of Medicine and Pharmacology and the Cardiovascular Research Institute, and Department of Pediatrics, University of California, San Francisco, California 94143

Cholera toxin acts by ADP-ribosylating a membrane protein, variously termed N, G, or G/F, that is a guanine nucleotide-binding regulatory component of adenylate cyclase. Membranes of several mammalian cells contain two peptides, of Mr = 42,000 and 52,000, which are radiolabeled by incubation with cholera toxin and [32P]NAD. Toxin activation of N in avian and human erythrocytes leads to significant radiolabeling only of the Mr = 42,000 peptide. Thus ADP-ribosylation of the Mr = 42,000 peptide appears to suffice for stimulation of adenylate cyclase, and no biological function has yet been assigned to the Mr = 52,000 peptide. We have found that incubation with toxin and [32P]NAD significantly radiolabels an Mr = 52,000 peptide, but not an Mr = 42,000 peptide in particulate preparations of A9 mouse and 380-6 hamster transformed lung fibroblasts. Treatment of intact A9 or 380-6 cells with cholera toxin increases their cyclic AMP content and blocks subsequent toxin-catalyzed incorporation of 32P from NAD into the Mr = 52,000 peptide of particulate extracts from the toxin-treated cells. Treating A9 and 380-6 particulate extracts with toxin and NAD increases their N activity in the presence of GTP, assayed using N-deficient membranes of the S49 cyc- mutant. We conclude that (1) a functionally active form of the N protein can contain the Mr = 52,000 peptide and (2) ADP-ribosylation of the Mr = 52,000 peptide subunit of N can mediate the action of cholera toxin.

Submitted on October 23, 1980
Accepted on January 13, 1981







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics